Golden has been acquired by ComplyAdvantage.Read about it here ⟶

RAPT Therapeutics

RAPT Therapeutics is a clinical-stage immunology-based therapeutics company focused on discovering, developing, and commercializing oral small molecule therapies for the treatment of inflammatory diseases and oncology.

Overview Structured Data Issues Contributors Activity

rapt.com

Is a

Organization

Company

Company attributes

Industry

Engineering

Biomedical engineering

Location

South San Francisco, California

B2X

CEO

Legal Name

RAPT Therapeutics, Inc.0

Legal classification

Public company

Number of Employees (Ranges)

51 – 2000

Email Address

inquiries@rapt.com

Phone Number

+16504899000

Number of Employees

830

Full Address

561 Eccles Avenue South San Francisco, CA 94080 United States0

CIK Number

1,673,772

Investors

Tim Hanlon

Founded Date

2015

Total Funding Amount (USD)

50,000,000

Latest Funding Round Date

June 2, 2022

Stock Symbol

RAPT0

Exchange

CFO

Former CEO

Acquisition Transaction

Patents Assigned (Count)

Country

United States

Other attributes

Company Operating Status

Active0

Latest Funding Round Amount (USD)

50,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like RAPT Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API